PDT Partners’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-69,066
Closed -$2.05M 850
2025
Q1
$2.05M Sell
69,066
-27,566
-29% -$1.05M 0.15% 245
2024
Q4
$3.83M Buy
96,632
+26,657
+38% +$1.01M 0.34% 82
2024
Q3
$2.38M Buy
+69,975
New +$1.97M 0.21% 166
2024
Q2
Sell
-13,867
Closed -$307K 756
2024
Q1
$307K Sell
13,867
-73,844
-84% -$1.8M 0.03% 528
2023
Q4
$2.41M Sell
87,711
-11
-0% -$266 0.27% 114
2023
Q3
$1.96M Buy
87,722
+11
+0% +$283 0.25% 131
2023
Q2
$2.23M Buy
87,711
+8,935
+11% +$217K 0.31% 103
2023
Q1
$1.76M Buy
+78,776
New +$1.9M 0.24% 149
2021
Q3
Sell
-14,000
Closed -$560K 922
2021
Q2
$560K Sell
14,000
-67,057
-83% -$2.87M 0.04% 494
2021
Q1
$4.36M Buy
81,057
+66,808
+469% +$3.85M 0.31% 104
2020
Q4
$697K Buy
14,249
+6,267
+79% +$290K 0.05% 392
2020
Q3
$259K Buy
+7,982
New +$254K 0.02% 575
2020
Q1
Sell
-10,400
Closed -$290K 867
2019
Q4
$290K Sell
10,400
-47,800
-82% -$1.24M 0.02% 550
2019
Q3
$1.4M Hold
58,200
0.08% 240
2019
Q2
$1.66M Buy
58,200
+26,900
+86% +$672K 0.1% 208
2019
Q1
$783K Buy
31,300
+2,500
+9% +$47.7K 0.04% 279
2018
Q4
$362K Sell
28,800
-13,000
-31% -$154K 0.02% 355
2018
Q3
$399K Sell
41,800
-755
-2% -$8.33K 0.02% 382
2018
Q2
$397K Sell
42,555
-5,645
-12% -$39.7K 0.02% 419
2018
Q1
$268K Sell
48,200
-370
-0.8% -$2.29K 0.01% 497
2017
Q4
$317K Buy
+48,570
New +$361K 0.01% 482

Other funds holding VCYT

PDT Partners's VCYT Position: Q2 2025 in Review

PDT Partners sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 69,066 shares — an estimated $2.05M sold.

PDT Partners first reported a position in VCYT in Q4 2017 and held it in 21 quarters. The position peaked at $4.36M in Q1 2021. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

  • PDT Partners reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
  • PDT Partners sold 69,066 Veracyte shares in Q2 2025, an estimated $2.05M.
  • PDT Partners first reported a position in Veracyte in Q4 2017 and held it in 21 quarters.
  • PDT Partners's Veracyte position peaked at $4.36M in Q1 2021.
  • 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.